title: [Statement of the German Airway League: Reimbursement of Osimertinib in Germany].
authors.affiliation: Gemeinschaftspraxis & Zentrum für Allergologie, Pneumologie, Schlafmedizin, Klinik Maingau vom Roten Kreuz, Frankfurt.
authors.forename: P
authors.initials: P
authors.lastname: Kardos
authors.affiliation: Krankenhaus Martha-Maria Halle-Dölau, Halle (Saale).
authors.forename: W
authors.initials: W
authors.lastname: Schütte
authors.affiliation: Ev. Krankenhaus Göttingen - Weende/Med. Klinik Abtlg. Beatmungsmedizin/Schlaflabor, Bovenden/Lenglern.
authors.forename: C-P
authors.initials: CP
authors.lastname: Criée
authors.affiliation: Facharztforum Fürth, Fürth.
authors.forename: H
authors.initials: H
authors.lastname: Worth
mesh_terms: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017277:Drug Approval / Q000458:organization & administration*; D017723:Drug Utilization Review / Q000458:organization & administration*; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D038622:Internationality; D008175:Lung Neoplasms / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D012955:Societies, Medical; D016896:Treatment Outcome; D007211:Indoles; D011743:Pyrimidines
chemical_list: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents; D010879:Piperazines; C000596361:osimertinib; D007211:Indoles; D011743:Pyrimidines